Home/Publication/Cowin Doubles Down on Flu Antivirals Developer
Cowin Doubles Down on Flu Antivirals Developer 

27 Jun 2024

US$ 19.00

Cowin Capital has made a follow-on investment in the over Rmb200 million (US$27.5 million) series A funding round of ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Subscribers’ Weekly ending 22 May 2026...

Once largely discreet and illusive in the private capital markets outside of their domains, they are now among the ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.